Advertisement
ALC vs BSX
Which Stock Would AI Choose? Alcon Inc. (ALC) vs. Boston Scientific Corporation (BSX) Stock Comparison
Key Takeaways
- ALC has shown resilience in recent market activity, posting modest year-to-date (YTD) gains around 1-2% and an 8% rise over the past month, contrasting with broader sector pressures.
- BSX has experienced significant YTD declines of approximately 33%, trading near its 52-week low amid heightened volatility in medtech stocks.
- Both companies operate in the medical technology sector, but ALC's focus on eye care provides narrower exposure compared to BSX's diversified cardiovascular and MedSurg portfolio.
- ALC boasts a market cap of about $40 billion with a P/E ratio (price-to-earnings ratio) of 40.6, while BSX has a larger $90 billion cap and P/E of 31.4.
- Recent sentiment for BSX reflects anticipation around upcoming Q1 earnings, with analysts noting potential strength in cardiovascular performance despite price target adjustments.
Introduction
This comparison examines ALC and BSX, two prominent players in the medical technology sector specializing in devices for eye care and cardiovascular interventions, respectively. Traders and investors tracking healthcare stocks may find value in understanding their relative performance amid recent market volatility, sector headwinds, and company-specific catalysts. With medtech facing pricing pressures and macroeconomic shifts, this analysis highlights differences in momentum, valuation, and positioning to inform stock comparison decisions in the current environment.
ALC Overview and Recent Performance
Alcon Inc. (ALC) is a global leader in eye care, operating through Surgical and Vision Care segments that provide intraocular lenses (IOLs), consumables for cataract surgery, contact lenses, and products for dry eye and glaucoma. Headquartered in Geneva, Switzerland, the company generates annual revenue exceeding $10 billion. In recent market activity, ALC stock has traded around $80-81, up about 8% over the past month and modestly higher YTD at 1-2%, outperforming many peers. Influences include the completion of a $750 million share repurchase program, signaling confidence, and steady demand for vision products. Lower beta (0.74) reflects relative stability, though shares remain below 52-week highs near $99 amid broader healthcare sentiment shifts.
BSX Overview and Recent Performance
Boston Scientific Corporation (BSX) develops and markets medical devices across MedSurg and Cardiovascular segments, addressing gastrointestinal, urological, neurological, and heart conditions with stents, pacemakers, and monitoring systems. Based in Marlborough, Massachusetts, it reports over $20 billion in trailing twelve-month (TTM) revenue. Recently, BSX shares have hovered near $61, down sharply YTD by about 33% and close to 52-week lows around $60.59, pressured by sector-wide declines from highs over $108. Key factors include anticipation for Q1 earnings on cardiovascular strength, offset by price target reductions and market volatility. Beta at 0.78 indicates moderate risk, with focus on innovations like left atrial appendage closure devices supporting long-term positioning.
Trending AI Robots
Tickeron’s Trending AI Robots page features a curated selection of 25 top-performing AI trading bots out of 351 total bots that trade thousands of tickers across stocks, ETFs, and crypto. These bots employ diverse strategies like swing trading, technical analysis (TA), and fundamental analysis (FA), with timeframes from 5 minutes to daily. Standout performers show annualized returns up to 121%, win rates of 55-87%, profit factors of 1.5-11.7, and profit-to-drawdown ratios exceeding 10 in some cases, often focusing on sectors like semiconductors, industrials, and precious metals. Selected for current market conditions, they offer real-time signals and risk management. Explore these bots to potentially enhance your trading with data-driven insights.
Head-to-Head Comparison
ALC and BSX both thrive in medtech but differ in focus: ALC specializes in eye care for stable, recurring demand, while BSX pursues broader growth via cardiovascular innovations and diversified procedures. Recent momentum favors ALC with upward trends versus BSX's pullback. Valuation shows BSX at a lower P/E but higher debt-to-equity (48.9% vs. 23.8%), implying trade-offs in risk. Sector exposure ties them to healthcare reimbursement risks, yet BSX benefits from larger scale and free cash flow ($3.2B TTM vs. $1.2B). Market sentiment leans cautious for both amid volatility, with ALC exhibiting stronger relative stability.
Tickeron AI Verdict
Tickeron’s AI currently leans toward ALC based on trend consistency, recent price momentum, and lower volatility in the prevailing market. While BSX holds catalysts like earnings potential, its sharper decline suggests elevated near-term risks. This positioning favors ALC probabilistically for traders seeking relative strength in medtech.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALC is a Hold and BSX is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ALC’s FA Score shows that 1 FA rating(s) are green whileBSX’s FA Score has 0 green FA rating(s).
- ALC’s FA Score: 1 green, 4 red.
- BSX’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ALC’s TA Score shows that 5 TA indicator(s) are bullish while BSX’s TA Score has 5 bullish TA indicator(s).
- ALC’s TA Score: 5 bullish, 2 bearish.
- BSX’s TA Score: 5 bullish, 3 bearish.
Price Growth
ALC (@Pharmaceuticals: Other) experienced а +0.43% price change this week, while BSX (@Medical/Nursing Services) price change was -2.81% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.32%. For the same industry, the average monthly price growth was -1.03%, and the average quarterly price growth was -14.58%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.52%. For the same industry, the average monthly price growth was -4.27%, and the average quarterly price growth was -16.56%.
Reported Earning Dates
ALC is expected to report earnings on Aug 10, 2026.
BSX is expected to report earnings on Jul 29, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (-2.32% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (-0.52% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| ALC | BSX | ALC / BSX | |
| Capitalization | 32.2B | 67.8B | 47% |
| EBITDA | 2.54B | 5.49B | 46% |
| Gain YTD | -16.102 | -52.176 | 31% |
| P/E Ratio | 39.03 | 18.55 | 210% |
| Revenue | 10.6B | 20.6B | 51% |
| Total Cash | 1.66B | 1.45B | 114% |
| Total Debt | 5.25B | 11B | 48% |
ALC | BSX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 9 | 55 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 18 Undervalued | 59 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 95 | |
SMR RATING 1..100 | 89 | 58 | |
PRICE GROWTH RATING 1..100 | 73 | 65 | |
P/E GROWTH RATING 1..100 | 49 | 98 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ALC's Valuation (18) in the Hospital Or Nursing Management industry is somewhat better than the same rating for BSX (59) in the Medical Specialties industry. This means that ALC’s stock grew somewhat faster than BSX’s over the last 12 months.
BSX's Profit vs Risk Rating (95) in the Medical Specialties industry is in the same range as ALC (100) in the Hospital Or Nursing Management industry. This means that BSX’s stock grew similarly to ALC’s over the last 12 months.
BSX's SMR Rating (58) in the Medical Specialties industry is in the same range as ALC (89) in the Hospital Or Nursing Management industry. This means that BSX’s stock grew similarly to ALC’s over the last 12 months.
BSX's Price Growth Rating (65) in the Medical Specialties industry is in the same range as ALC (73) in the Hospital Or Nursing Management industry. This means that BSX’s stock grew similarly to ALC’s over the last 12 months.
ALC's P/E Growth Rating (49) in the Hospital Or Nursing Management industry is somewhat better than the same rating for BSX (98) in the Medical Specialties industry. This means that ALC’s stock grew somewhat faster than BSX’s over the last 12 months.
| ALC | BSX | |
|---|---|---|
| RSI ODDS (%) | 6 days ago 46% | 1 day ago 79% |
| Stochastic ODDS (%) | 1 day ago 65% | 1 day ago 57% |
| Momentum ODDS (%) | 1 day ago 66% | 1 day ago 49% |
| MACD ODDS (%) | 1 day ago 60% | 1 day ago 53% |
| TrendWeek ODDS (%) | 1 day ago 49% | 1 day ago 54% |
| TrendMonth ODDS (%) | 1 day ago 51% | 1 day ago 59% |
| Advances ODDS (%) | 1 day ago 57% | 15 days ago 57% |
| Declines ODDS (%) | 8 days ago 56% | 9 days ago 54% |
| BollingerBands ODDS (%) | N/A | 1 day ago 71% |
| Aroon ODDS (%) | 1 day ago 43% | 1 day ago 66% |
Advertisement
ALC and
Correlation & Price change
A.I.dvisor indicates that over the last year, ALC has been loosely correlated with SYK. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ALC jumps, then SYK could also see price increases.
BSX and
Correlation & Price change
A.I.dvisor indicates that over the last year, BSX has been closely correlated with ISRG. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if BSX jumps, then ISRG could also see price increases.
| Ticker / NAME | Correlation To BSX | 1D Price Change % | ||
|---|---|---|---|---|
| BSX | 100% | +2.86% | ||
| ISRG - BSX | 71% Closely correlated | +0.06% | ||
| MMSI - BSX | 56% Loosely correlated | +1.16% | ||
| ALC - BSX | 49% Loosely correlated | +1.44% | ||
| NTRA - BSX | 45% Loosely correlated | +2.60% | ||
| A - BSX | 44% Loosely correlated | +0.14% | ||
More | ||||